![Stephan Kontos](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephan Kontos
Direttore/Membro del Consiglio presso Aperiam Bio, Inc.
Profilo
Stephan is an Entrepreneur-in-Residence based in Versant’s San Francisco office.
He brings deep operational and international business experience in early stage companies, as well as expertise in immunology and protein engineering to new company creation.
Prior to joining Versant, Stephan was Chief Scientific Officer of Anokion, a company he co-founded based on work from his doctoral thesis.
At Anokion, he defined and led R&D efforts to achieve successful human translation of a novel immune-based platform technology to treat autoimmune diseases.
Stephan holds a BSc in Chemical Engineering from the University of Texas and a Ph.D.
in Bioengineering from the Swiss Federal Institute of Technology in Lausanne.
Posizioni attive di Stephan Kontos
Società | Posizione | Inizio |
---|---|---|
Aperiam Bio, Inc.
![]() Aperiam Bio, Inc. BiotechnologyHealth Technology Aperiam Bio, Inc. is a biotechnology company that develops skincare products. The company is based in Austin, TX. The CEO of the company is Cole Austin. | Direttore/Membro del Consiglio | 01/03/2022 |
Precedenti posizioni note di Stephan Kontos
Società | Posizione | Fine |
---|---|---|
Versant Venture Management LLC
![]() Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investitore di Private Equity | 01/05/2024 |
Anokion SA
![]() Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Fondatore | 01/10/2022 |
Kanyos Bio, Inc.
![]() Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Fondatore | - |
Formazione di Stephan Kontos
The University of Texas at Austin | Undergraduate Degree |
Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Versant Venture Management LLC
![]() Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
Anokion SA
![]() Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
Kanyos Bio, Inc.
![]() Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Aperiam Bio, Inc.
![]() Aperiam Bio, Inc. BiotechnologyHealth Technology Aperiam Bio, Inc. is a biotechnology company that develops skincare products. The company is based in Austin, TX. The CEO of the company is Cole Austin. | Health Technology |
- Borsa valori
- Insiders
- Stephan Kontos